Navigation Links
Sperm's immune-protection properties could provide link to how cancers spread
Date:12/13/2007

Sugar-based markers on human sperm cells which may prevent them from being attacked by the female immune system could provide a vital clue to how some cancers spread in the human body, according to new research published on 14 December 2007.

The new research, currently available online in the Journal of Biological Chemistry, analysed these markers which are believed to tell the female immune system that the sperm are not dangerous pathogens, and therefore should not be attacked by the womans white blood cells during the reproductive process. The study, led by Imperial College London and the University of Missouri, suggests that these sugar markers, found on N-glycans which are part of human sperm glycoproteins, can be universally recognised by all human immune systems, regardless of the individual.

Professor Anne Dell from Imperial College Londons Department of Life Sciences, one of the studys lead authors, said: Normal human cells carry chemical markers made of proteins which tell the immune system not to attack them. In the case of organ transplants, for example, doctors try to match these markers in both the donor and the recipient to prevent rejection. However, in the case of sperm cells, their sugar-based markers are different: they are recognised by everyones immune system, meaning that no immune response is triggered during reproduction between any two people.

This kind of marker is also found on some types of cancer cells, some bacterial cells, some parasitic worms and HIV infected white blood cells. The scientists believe that these markers allow such dangerous cells and pathogens to evade destruction by the human immune system, leading to serious sometimes fatal - illness.

Professor Dell explains that understanding how this basic biology works on sperm cells may lead to greater knowledge of how some serious diseases and infections manage to win the battle with the human immune system. She says:

If ag
'/>"/>

Contact: Danielle Reeves
danielle.reeves@imperial.ac.uk
44-020-759-42198
Imperial College London
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
2. All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
3. Researchers identify molecules with interesting anti-clotting properties
4. Landmark trial to evaluate cardioprotective properties of insulin
5. The HealthCentral Network Adds Skin Care Site to Its Web Properties
6. Study provides hope that some transplant patients could live free of antirejection drugs
7. Study provides hope that some transplant patients could live free of anti-rejection drugs
8. HIV denialists spread misinformation online -- consequences could be deadly; and more
9. Virus Could Help Drive Obesity
10. Discovery of sugar sensor in intestine could benefit diabetes
11. Cranberry Could Juice Up Ovarian Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...Story Project was announced today as the new brand...nical Document Architecture for Common Document Ty... label for the technical standards developed by th...) for ballot. The new name , ...- "Our group has been working with many part...
(Date:12/2/2008)...d to feel about 13 years younger than their chrono...study forthcoming in the Journals of Gerontology:...the responses of 516 men and women age 70 and olde...king how their perceptions about age and their sat...d. , "People generally felt quite a bit younger ...
(Date:12/2/2008)...ch . , Deep venous thrombosis (DVT), the forma...rd-most common vascular disease in North America a...mplication in hospitalized patients. DVT is a pote...eath from pulmonary embolism if untreated, and has.... Surgeon General and the Canadian Safer Healthcar...
(Date:12/2/2008)...wswire-USNewswire/ -- On Thursday December 4th Go...s at eHealth Initiative,s conference in Washington...ritical Review of Progress Over the Last Five Year... , (Logo: http://www.newscom.com/cgi-bin/pr...h will begin at 4:30 p.m. For more information ple...
Breaking Medicine News(10 mins):Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:Thrombosis patients face greater risks than previously believed 2
... a fair distribution of bird flu vaccines, the Wor...global stockpile of vaccines// for developing coun...t importance in the fight against avian influenza,...ret Chan was quoted as saying by The Jakarta Post ...
...in England and Wales have been accused of being in...or doctors say that//, although services are pione...o go before they meet the challenges of a multi-cu...sus, published last week by the Healthcare Commiss...
...ntiviral drugs during a recent influenza B epidemi...partial resistance to the drugs//, according to a ...ivir, which are a type of drugs known as neuramini...gainst influenza and are used extensively. There h...
...in Alberta empowers pharmacists to prescribe medic...s. Now, pharmacists in Alberta// will be allowed t...tions and make modifications to dosages or prescri... ruling has received widespread acclaim, there are...
Other Medicine News:Health News:Chances of Tackling Racism in Mental Health Care is Still Remote 2Health News:Study Suggests Some Drug Resistance to Influenza B Medications 2
(Date:12/1/2008)...ude study shows the Prox1 gene is a two-way switch... cells to be reprogrammed so that they lose their ...lls , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-...Research Hospital have discovered that a certain d...identity that it requires the constant expression ...
(Date:12/1/2008)...UTH MEETING, Pa., Dec. 1 ...unced that dosing of subjects has begun in study M...ose Phase 1b study of trodusquemine (MSI-1436) in ... a novel therapeutic for the treatment of type 2 d...pherally to regulate insulin and leptin pathways t...
(Date:12/1/2008)...nference Call Scheduled for Tuesday, December 9 at...ML -- , , SOUTH SAN FRANCISCO, Calif., Dec...icals, Inc. (Nasdaq: SNSS ), a biopharmaceutical...ization of new oncology therapeutics, today announ...e myeloid leukemia (AML) will be presented during ...
(Date:12/1/2008)...IEGO, Dec. 1 Vical Incor...ipt of a $1.0 million milestone payment from Merck...on of a Phase I clinical trial of an investigation...e vaccine is based on Vical,s DNA gene delivery te...scriptase (hTERT). hTERT is the subject of separat...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2 26 23163 3B28 5M investment for groundbreaking new research facility 24358 1 26 23163 3B28 5M investment for groundbreaking new research facility 24358 2Study 3A Typhoons bury tons of carbon in the oceans 4184 1Study 3A Typhoons bury tons of carbon in the oceans 4184 2Study 3A Typhoons bury tons of carbon in the oceans 4184 3Study 3A Typhoons bury tons of carbon in the oceans 4184 4The Connecticut Hospice Inc Announces the Arrival of Six Nurse Scholars From The Henrietta Szold Hadassah Hebrew University School of Nursing 24355 1SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 1SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 2SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 3SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 4
...ed, the Hutchison Whampoa backed pharmaceutical an...ts for its Phase II,proof-of-concept study for HMP...rm of inflammatory bowel disease. The trial met,i...nd showed an,equivalent drop in clinical symptom s...nt first-line standard of care in,mild-to-moderate...
... Pharmaceuticals (AIM:CEN),("CeNeS" or "the Compan...today announced that a paper published this week i...t a,catechol-O-methyltransferase (COMT) inhibitor ...address profound cognitive,deficits in schizophren...overy programme to develop novel COMT inhibitors. ...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4
It has long been a standard requirement for smoke evacuation to be used during laser procedures, however, many in the healthcare industry contend that smoke plume generated from electrosurgical proce
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery
...e Dornier Medilas D Fibertom is a 60 watt diode co...use of Diode Power Bar technology and 940 nm wavel...ous laser treatment for varicose veins and a varie...m also includes unique safety features including t...
imEXPRESS uses the control panel and setup wizard concept (familiar to any Windows user) allowing you to quickly and easily connect and control your instruments.
Medicine Products: